We are live on ! Find out more
HOOK icon

HOOKIPA Pharma

Delisted

HOOK was delisted on the 7th of August, 2025.

35 hedge funds and large institutions have $49.7M invested in HOOKIPA Pharma in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

490% more capital inflows, than outflows

Capital inflows: $6.62M | Capital outflows: $1.12M

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

75% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 8

6% more funds holding

Funds holding: 33 → 35 (+2)

0.35% more ownership

Funds ownership: 30.35% → 30.7% (+0.35%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
35
Holders Change
+2
Holders Change %
+6.06%
% of All Funds
0.76%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
14
Reduced
8
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

HOOK Hedge Fund Activity: Q3 2019 in Review

35 of the 4,577 institutional investors tracked by Wall St. Rank reported a position in HOOKIPA Pharma (HOOK) for Q3 2019, worth a combined $49.7M — up 13% from $44.1M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new HOOK positions and 3 closed out — a net gain of 3 holders — while 14 added to existing stakes and 8 trimmed.

The largest buyer was HHLR Advisors, adding an estimated $4.85M. The largest seller was Millennium Management, exiting entirely with an estimated $328K sold.

  • 35 institutional investors held HOOKIPA Pharma (HOOK) as of Q3 2019, up from 33 in Q2 2019.
  • Funds reported $49.7M of HOOKIPA Pharma stock for Q3 2019, up 13% quarter-over-quarter.
  • 6 funds opened new HOOKIPA Pharma positions in Q3 2019 and 3 closed out, a net change of +3 holders.
  • The largest HOOKIPA Pharma buyer in Q3 2019 was HHLR Advisors, an estimated $4.85M added.
  • The largest HOOKIPA Pharma seller in Q3 2019 was Millennium Management, an estimated $328K sold.

Based on aggregated 13F filings for Q3 2019.